Vicore to kickstart Phase IIb IPF trial for buloxibutid
Vicore Pharma will initiate the Phase IIb trial by the end of H1 2024.
Source: yahoo.com
Stay updated with breaking news from Both Ofev. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vicore Pharma will initiate the Phase IIb trial by the end of H1 2024.